Idiopathic pulmonary fibrosis and lung cancer: from bench to bedside
Aims : To identify common molecular pathways that could be future therapeutic targets for idiopathic pulmonary fibrosis (IPF) and lung cancer; to present novel epidemiological and clinical data from real life registries; to describe management and diagnostic evaluation of these patients; to present the need of multidisciplinary assessment between pulmonologists, radiologists, histopathologists, thoracic surgeons and oncologists; to identify complications of therapeutic agents in the field such as immunotherapy; to present the need of increased funding for medical research.
Target audience :
Adult pulmonologist/Clinician, Clinical researcher, General practitioner, Respiratory therapist, Medical Student, Medical Technical Assistant, Nurse, Pathologist, Patient, Physician in Pulmonary Training, Physiologist, Radiologist, Respiratory critical care physician, Respiratory physiotherapist, Journalist, Scientist (basic, translational), Thoracic oncologist, Thoracic surgeon
Cell and molecular biology, Endoscopy and interventional pulmonology, Epidemiology